-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
IDG Capital
- Investments: 1456
- Funds: 140
- Beijing
-
Energy storage
-
Photovoltaic
-
Hydrogen energy
-
Lithium batteries
-
Electric vehicles
-
Grid/power transmission
-
New materials
-
Industrial manufacturing
-
Green transportation
IDG Capital, founded in 1992, is a leading investment institution in the world, focusing on supporting outstanding enterprises in different growth cycles to achieve rapid development through venture capital, private equity and industrial development. IGD Capital has invested in more than 1,400 enterprises including 360, Baidu, Ctrip.com, Afu Essential Oil, Andon Medical, Archermind, Baofeng, Bilibili, Cobos, Bosideng, Birentech, China UMS, Fftai, Heytea, Iqiyi, Ijovo and Three Squirrels. IDG Capital has one of the most complete and experienced professional teams in the industry. The team members have diversified industry backgrounds and global investment perspectives and resources, and their education and working backgrounds cover many industries such as technology, market, finance, law, management consulting and investment banking.
-
ASB Ventures
- Investments: 76
- Funds: 10
- Shenzhen, Guangdong Province
-
Grid/power transmission
-
Circular economy
ASB Ventures officially entered mainland China and jointly established a RMB private equity investment fund management institution-Shenzhen Huaao Capital Management Co., Ltd. with professional institutions, including China Venture Capital Co., LTD and Shenzhen United Property and Equity Exchange in 2009. In 2015, we adjusted the equity and changed our name to Shenzhen ASB Ventures Management Co., Ltd. The funds under ASB Ventures include ASB New Industry Venture Capital FOF and Huaao Venture Capital Series Funds (No. I-V)---two RMB private equity venture capital funds independently managed by Shenzhen ASB Ventures Management Co., Ltd. and our holding subsidiaries, and ASB China Fund (No. I-IV), an offshore US dollar family venture capital fund independently managed by ABS China Holdings Co., Ltd. We focus on venture capital in the fields of biomedicine and health, TMT and creativity, and hardware technology and clean technology (in the form of FOF combined with direct investment in projects), and private investment fund management. We also provide high quality financial and governance services.
-
Sinvation Ventures
- Investments: 618
- Funds: 13
- Beijing
-
Energy storage
-
Photovoltaic
-
Green transportation
-
Digital technology for carbon accounting and consulting
Sinovation Ventures was founded by Dr. Kai-Fu Lee in September 2009. As a leading technology-based venture capital institution in China, Sinovation Ventures is deeply involved in the fields of artificial intelligence and hard technology, robotics and automation, chips/semiconductors, corporate service software, medical technology, sustainable technology, etc., and constantly explores and innovates, and is committed to building an all-round ecological investment service platform integrating entrepreneurial platforms, financial support and post-investment services. Sinovation Ventures' investment fields include artificial intelligence and hard technology, robot automation, corporate service software, semiconductors, chips, medical technology, sustainable technology, etc. Sinovation Ventures has invested in more than 100 enterprises, including AInnovation, Zhihu, Niu Technologies, Mobike, Meitu, Ink Weather, Renren Video, etc. Sinovation Ventures always adheres to the principles of environmental friendliness, social responsibility, business ethics, management and community participation, and helps Chinese entrepreneurs build world-class enterprises.
-
Frees Fund
- Investments: 312
- Funds: 14
- Shanghai
-
Lithium batteries
-
Low-carbon consumer goods
-
Green transportation
-
Circular economy
Frees Fund is committed to making future-oriented investment, so it has become the first-round institutional investor of many forward-looking enterprises with original innovation ability. Consumption and TMT, high technology and biomedicine are the three major investment directions of Frees Fund. Frees Fund has invested in more than 150 innovative enterprises, covering lifestyle, culture and entertainment, finance, intelligent manufacturing, artificial intelligence, biotechnology and new drug research and development, new energy and new materials, and so on. Frees' portfolio not only includes Three Squirrels, 360 DigiTech, Uber Global, Unity and other listed companies, but also many innovative enterprises with high growth, including Qingtao Development, Xtaipi, Patpat, Coyote Bio, Robot Phoenix, Saturnbird Coffee, Pyrotech Therapeutics and so on.
-
GTJA Investment Group
- Investments: 134
- Funds: 87
- Shenzhen, Guangdong Province
-
Lithium batteries
-
Electric vehicles
-
Bio-Tech
Founded in Shenzhen in 2001, GTJA Investment Group focuses on investment in the medical health industry and is dominated by strategic equity investment, covering all stages of mergers and acquisitions, PE, VC, and angels. We have a medical investment team with leading scale and professionalism in China to build a ecoplatform for medical health industry. We are committed to becoming a medical health investment institution with global influence. GTJA's investment layout includes biopharmaceuticals, medical devices and medical services. With an asset management scale of over 20 billion RMB and 35 medical health industry funds, we have invested in more than 160 companies, including more than 90 medical health companies, and promoted the successful listing of 34 companies.